Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis
Veronika A. Myasoedova, Valentina Parisi, Donato Moschetta, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
Milton Packer, Michael R. Zile, Christopher M. Kramer, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 60
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium–Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure
Giovanna Gallo, Massimo Volpe
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2484-2484
Open Access | Times Cited: 10
Excessive accumulation of epicardial adipose tissue promotes microvascular obstruction formation after myocardial ischemia/reperfusion through modulating macrophages polarization
Jinxuan Zhao, Wei Cheng, Yang Dai, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Emerging Pharmacotherapies for Obesity: A Systematic Review
Michail Kokkorakis, Marlene Chakhtoura, Caline Rhayem, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100002-100002
Open Access | Times Cited: 7
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure
Christopher M. Kramer, Barry A. Borlaug, Michael R Zile M, et al.
Journal of the American College of Cardiology (2024)
Open Access | Times Cited: 6
Roles of perivascular adipose tissue in the pathogenesis of atherosclerosis ― an update on recent findings
Tomoya Hara, Masataka Sata
Frontiers in Physiology (2025) Vol. 15
Open Access
Cardiac magnetic resonance quantified epicardial fat volume is associated with complex coronary artery disease among diabetics
Shimaa Khidr, Bakeer Mohamed Bakeer, Hatem Abdel-Rahman Helmy, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Proarrhythmic Lipid Inflammatory Mediators: Mechanisms in Obesity Arrhythmias
Pegah Bahrami Taqanaki, Kelly A. Aromolaran, Ademuyiwa S. Aromolaran
Journal of Cellular Physiology (2025) Vol. 240, Iss. 2
Open Access
Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential
Zhongwen Qi, Dan Wu, Zhipeng Yan, et al.
Obesity Reviews (2025)
Open Access
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes
Francesca Cinti, Lucia Leccisotti, Gian Pio Sorice, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: recent advances classified by research methodologies
Yujie Song, Yanzhen Tan, Meng Deng, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 11
The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis
Panagiotis Stachteas, Paschalis Karakasis, Dimitrios Patoulias, et al.
Annals of Medicine (2023) Vol. 55, Iss. 2
Open Access | Times Cited: 11
Pericardium, epicardial adipose tissue, and heart failure with preserved ejection fraction: Pathophysiology, quantification and treatment target
Ana Teresa Timóteo, Francisco Barbas de Albuquerque, Bárbara Lacerda Teixeira
International Journal of Cardiology (2024) Vol. 412, pp. 132303-132303
Open Access | Times Cited: 3
Relationship between epicardial adipose tissue and coronary atherosclerosis by CCTA in young adults (18–45)
Annalisa Filtz, Daniel Lorenzatti, Andrea Scotti, et al.
American Journal of Preventive Cardiology (2024) Vol. 19, pp. 100711-100711
Open Access | Times Cited: 3
Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling
Jason Stencel, Hamid R. Alai, Aneesh Dhorepatil, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3341-3341
Open Access | Times Cited: 9
Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists
Veronika A. Myasoedova, Michele Bozzi, Vincenza Valerio, et al.
Antioxidants (2023) Vol. 13, Iss. 1, pp. 16-16
Open Access | Times Cited: 9
Venous thrombosis and obesity: from clinical needs to therapeutic challenges
Federica La Rosa, Fabrizio Montecucco, Luca Liberale, et al.
Internal and Emergency Medicine (2024)
Open Access | Times Cited: 2
Potential Mechanisms of Epicardial Adipose Tissue Influencing Heart Failure with Preserved Ejection Fraction
Qiuxuan Li, Ur Rehman Muhib, Xiaoteng Ma, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 9
Open Access | Times Cited: 2
Heart Failure and Obesity
Just Dronkers, Dirk J. van Veldhuisen, Peter van der Meer, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 17, pp. 1666-1677
Closed Access | Times Cited: 2
The Off-Target Cardioprotective Mechanisms of Sodium–Glucose Cotransporter 2 Inhibitors: An Overview
Loredana N. Ionică, Adina V. Lința, Alina D. Bătrîn, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7711-7711
Open Access | Times Cited: 2
Increased epicardial adipose tissue is associated with left ventricular reverse remodeling in dilated cardiomyopathy
Yuanwei Xu, Jiajun Guo, Yangjie Li, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Epicardial fat and ventricular arrhythmias
Marta Załęska‐Kocięcka, Zuzanna Wojdyńska, Małgorzata Kalisz, et al.
Heart Rhythm (2023) Vol. 21, Iss. 2, pp. 206-212
Closed Access | Times Cited: 5
The relationship between epicardial adipose tissue volume on coronary computed tomography angiography and idiopathic ventricular tachycardia: a propensity score matching case-control study in Chinese population
Zhe Wang, Jiawei Chen, Hehe Guo, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 1, pp. 29-37
Open Access | Times Cited: 1
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Aneesh Dhorepatil, Daniela Urina-Jassir, Rohan Samson, et al.
Current Hypertension Reports (2024) Vol. 26, Iss. 9, pp. 381-388
Open Access | Times Cited: 1
Efficacy of statin therapy in reducing epicardial adipose tissue: a systematic review and meta-analysis
Tannaz Jamialahmadi, Luis E. Simental‐Mendía, Ali H. Eid, et al.
Archives of Medical Science (2024) Vol. 20, Iss. 3, pp. 997-1001
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top